MedPath

安徽四环科宝制药有限公司

Ownership
-
Established
2018-06-11
Employees
-
Market Cap
-
Website
ahshkb.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

Levocarnitine Oral Solution

Product Name
左卡尼汀口服溶液
Approval Number
国药准字H20254529
Approval Date
Jun 10, 2025
NMPA

Desloratadine Oral Solution

Product Name
地氯雷他定口服溶液
Approval Number
国药准字H20253987
Approval Date
Apr 22, 2025
NMPA

Desloratadine Oral Solution

Product Name
地氯雷他定口服溶液
Approval Number
国药准字H20253986
Approval Date
Apr 22, 2025
NMPA

Clindamycin Phosphate Topical Solution

Product Name
克林霉素磷酸酯外用溶液
Approval Number
国药准字H20253605
Approval Date
Mar 11, 2025
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20253390
Approval Date
Feb 20, 2025
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20253391
Approval Date
Feb 20, 2025
NMPA

Salbutamol Sulfate Oral Solution

Product Name
硫酸沙丁胺醇口服溶液
Approval Number
国药准字H20253364
Approval Date
Feb 11, 2025
NMPA

Levofloxacin Oral Solution

Product Name
左氧氟沙星口服溶液
Approval Number
国药准字H20253126
Approval Date
Jan 14, 2025
NMPA

Levofloxacin Tablets

Product Name
左氧氟沙星片
Approval Number
国药准字H20244660
Approval Date
Aug 20, 2024
NMPA

Valsartan Tablets

Product Name
缬沙坦片
Approval Number
国药准字H20244229
Approval Date
Jun 28, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.